Global Drug Safety Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

January 2025 | 160 pages | ID: G0AF2B8F3C51EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Drug Safety Testing market size was valued at US$ 8801 million in 2024 and is forecast to a readjusted size of USD 28610 million by 2031 with a CAGR of 18.6% during review period.

The drug safety testing service is a commercial service that helps pharmaceutical companies and other companies to conduct drug component analysis and safety testing
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Drug Safety Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Drug Safety Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug Safety Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug Safety Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug Safety Testing market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Safety Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Safety Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ArisGlobal LLC, Eurofins, Clario, Charles River, Pace Analytical Services, LabCorp, ICON plc., Boston Analytical, Catalent, Parexel International Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Drug Safety Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
- Drug Testing
- Drug Analysis

Market segment by Application
- Pharmaceutical Company
- Biotechnology Company
- Medical Device Manufacturer
- Other

Market segment by players, this report covers
- ArisGlobal LLC
- Eurofins
- Clario
- Charles River
- Pace Analytical Services
- LabCorp
- ICON plc.
- Boston Analytical
- Catalent
- Parexel International Corporation
- Altasciences
- Hangzhou Huante Biotechnology Co., Ltd.
- Boende Testing
- Microspectroscopy Technology Co., Ltd.
- Pharmaron
- JOINN
- Shanghai InnoStar Bio-tech Co., Ltd
- WESTCHINA-FRONTIE PHARMA TECH
- Shanghai Medicilon
- Hangzhou Rongchuang Biological Co., Ltd.
- WuXi AppTec

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:


Chapter 1, to describe Drug Safety Testing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Drug Safety Testing, with revenue, gross margin, and global market share of Drug Safety Testing from 2020 to 2025.

Chapter 3, the Drug Safety Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Safety Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Safety Testing.

Chapter 13, to describe Drug Safety Testing research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Safety Testing by Type
  1.3.1 Overview: Global Drug Safety Testing Market Size by Type: 2020 Versus 2024 Versus 2031
  1.3.2 Global Drug Safety Testing Consumption Value Market Share by Type in 2024
  1.3.3 Drug Testing
  1.3.4 Drug Analysis
1.4 Global Drug Safety Testing Market by Application
  1.4.1 Overview: Global Drug Safety Testing Market Size by Application: 2020 Versus 2024 Versus 2031
  1.4.2 Pharmaceutical Company
  1.4.3 Biotechnology Company
  1.4.4 Medical Device Manufacturer
  1.4.5 Other
1.5 Global Drug Safety Testing Market Size & Forecast
1.6 Global Drug Safety Testing Market Size and Forecast by Region
  1.6.1 Global Drug Safety Testing Market Size by Region: 2020 VS 2024 VS 2031
  1.6.2 Global Drug Safety Testing Market Size by Region, (2020-2031)
  1.6.3 North America Drug Safety Testing Market Size and Prospect (2020-2031)
  1.6.4 Europe Drug Safety Testing Market Size and Prospect (2020-2031)
  1.6.5 Asia-Pacific Drug Safety Testing Market Size and Prospect (2020-2031)
  1.6.6 South America Drug Safety Testing Market Size and Prospect (2020-2031)
  1.6.7 Middle East & Africa Drug Safety Testing Market Size and Prospect (2020-2031)

2 COMPANY PROFILES

2.1 ArisGlobal LLC
  2.1.1 ArisGlobal LLC Details
  2.1.2 ArisGlobal LLC Major Business
  2.1.3 ArisGlobal LLC Drug Safety Testing Product and Solutions
  2.1.4 ArisGlobal LLC Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.1.5 ArisGlobal LLC Recent Developments and Future Plans
2.2 Eurofins
  2.2.1 Eurofins Details
  2.2.2 Eurofins Major Business
  2.2.3 Eurofins Drug Safety Testing Product and Solutions
  2.2.4 Eurofins Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.2.5 Eurofins Recent Developments and Future Plans
2.3 Clario
  2.3.1 Clario Details
  2.3.2 Clario Major Business
  2.3.3 Clario Drug Safety Testing Product and Solutions
  2.3.4 Clario Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.3.5 Clario Recent Developments and Future Plans
2.4 Charles River
  2.4.1 Charles River Details
  2.4.2 Charles River Major Business
  2.4.3 Charles River Drug Safety Testing Product and Solutions
  2.4.4 Charles River Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.4.5 Charles River Recent Developments and Future Plans
2.5 Pace Analytical Services
  2.5.1 Pace Analytical Services Details
  2.5.2 Pace Analytical Services Major Business
  2.5.3 Pace Analytical Services Drug Safety Testing Product and Solutions
  2.5.4 Pace Analytical Services Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.5.5 Pace Analytical Services Recent Developments and Future Plans
2.6 LabCorp
  2.6.1 LabCorp Details
  2.6.2 LabCorp Major Business
  2.6.3 LabCorp Drug Safety Testing Product and Solutions
  2.6.4 LabCorp Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.6.5 LabCorp Recent Developments and Future Plans
2.7 ICON plc.
  2.7.1 ICON plc. Details
  2.7.2 ICON plc. Major Business
  2.7.3 ICON plc. Drug Safety Testing Product and Solutions
  2.7.4 ICON plc. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.7.5 ICON plc. Recent Developments and Future Plans
2.8 Boston Analytical
  2.8.1 Boston Analytical Details
  2.8.2 Boston Analytical Major Business
  2.8.3 Boston Analytical Drug Safety Testing Product and Solutions
  2.8.4 Boston Analytical Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.8.5 Boston Analytical Recent Developments and Future Plans
2.9 Catalent
  2.9.1 Catalent Details
  2.9.2 Catalent Major Business
  2.9.3 Catalent Drug Safety Testing Product and Solutions
  2.9.4 Catalent Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.9.5 Catalent Recent Developments and Future Plans
2.10 Parexel International Corporation
  2.10.1 Parexel International Corporation Details
  2.10.2 Parexel International Corporation Major Business
  2.10.3 Parexel International Corporation Drug Safety Testing Product and Solutions
  2.10.4 Parexel International Corporation Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.10.5 Parexel International Corporation Recent Developments and Future Plans
2.11 Altasciences
  2.11.1 Altasciences Details
  2.11.2 Altasciences Major Business
  2.11.3 Altasciences Drug Safety Testing Product and Solutions
  2.11.4 Altasciences Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.11.5 Altasciences Recent Developments and Future Plans
2.12 Hangzhou Huante Biotechnology Co., Ltd.
  2.12.1 Hangzhou Huante Biotechnology Co., Ltd. Details
  2.12.2 Hangzhou Huante Biotechnology Co., Ltd. Major Business
  2.12.3 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product and Solutions
  2.12.4 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.12.5 Hangzhou Huante Biotechnology Co., Ltd. Recent Developments and Future Plans
2.13 Boende Testing
  2.13.1 Boende Testing Details
  2.13.2 Boende Testing Major Business
  2.13.3 Boende Testing Drug Safety Testing Product and Solutions
  2.13.4 Boende Testing Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.13.5 Boende Testing Recent Developments and Future Plans
2.14 Microspectroscopy Technology Co., Ltd.
  2.14.1 Microspectroscopy Technology Co., Ltd. Details
  2.14.2 Microspectroscopy Technology Co., Ltd. Major Business
  2.14.3 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product and Solutions
  2.14.4 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.14.5 Microspectroscopy Technology Co., Ltd. Recent Developments and Future Plans
2.15 Pharmaron
  2.15.1 Pharmaron Details
  2.15.2 Pharmaron Major Business
  2.15.3 Pharmaron Drug Safety Testing Product and Solutions
  2.15.4 Pharmaron Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.15.5 Pharmaron Recent Developments and Future Plans
2.16 JOINN
  2.16.1 JOINN Details
  2.16.2 JOINN Major Business
  2.16.3 JOINN Drug Safety Testing Product and Solutions
  2.16.4 JOINN Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.16.5 JOINN Recent Developments and Future Plans
2.17 Shanghai InnoStar Bio-tech Co., Ltd
  2.17.1 Shanghai InnoStar Bio-tech Co., Ltd Details
  2.17.2 Shanghai InnoStar Bio-tech Co., Ltd Major Business
  2.17.3 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product and Solutions
  2.17.4 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.17.5 Shanghai InnoStar Bio-tech Co., Ltd Recent Developments and Future Plans
2.18 WESTCHINA-FRONTIE PHARMA TECH
  2.18.1 WESTCHINA-FRONTIE PHARMA TECH Details
  2.18.2 WESTCHINA-FRONTIE PHARMA TECH Major Business
  2.18.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product and Solutions
  2.18.4 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.18.5 WESTCHINA-FRONTIE PHARMA TECH Recent Developments and Future Plans
2.19 Shanghai Medicilon
  2.19.1 Shanghai Medicilon Details
  2.19.2 Shanghai Medicilon Major Business
  2.19.3 Shanghai Medicilon Drug Safety Testing Product and Solutions
  2.19.4 Shanghai Medicilon Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.19.5 Shanghai Medicilon Recent Developments and Future Plans
2.20 Hangzhou Rongchuang Biological Co., Ltd.
  2.20.1 Hangzhou Rongchuang Biological Co., Ltd. Details
  2.20.2 Hangzhou Rongchuang Biological Co., Ltd. Major Business
  2.20.3 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product and Solutions
  2.20.4 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.20.5 Hangzhou Rongchuang Biological Co., Ltd. Recent Developments and Future Plans
2.21 WuXi AppTec
  2.21.1 WuXi AppTec Details
  2.21.2 WuXi AppTec Major Business
  2.21.3 WuXi AppTec Drug Safety Testing Product and Solutions
  2.21.4 WuXi AppTec Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
  2.21.5 WuXi AppTec Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Drug Safety Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
  3.2.1 Market Share of Drug Safety Testing by Company Revenue
  3.2.2 Top 3 Drug Safety Testing Players Market Share in 2024
  3.2.3 Top 6 Drug Safety Testing Players Market Share in 2024
3.3 Drug Safety Testing Market: Overall Company Footprint Analysis
  3.3.1 Drug Safety Testing Market: Region Footprint
  3.3.2 Drug Safety Testing Market: Company Product Type Footprint
  3.3.3 Drug Safety Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Drug Safety Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Drug Safety Testing Market Forecast by Type (2026-2031)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Drug Safety Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Drug Safety Testing Market Forecast by Application (2026-2031)

6 NORTH AMERICA

6.1 North America Drug Safety Testing Consumption Value by Type (2020-2031)
6.2 North America Drug Safety Testing Market Size by Application (2020-2031)
6.3 North America Drug Safety Testing Market Size by Country
  6.3.1 North America Drug Safety Testing Consumption Value by Country (2020-2031)
  6.3.2 United States Drug Safety Testing Market Size and Forecast (2020-2031)
  6.3.3 Canada Drug Safety Testing Market Size and Forecast (2020-2031)
  6.3.4 Mexico Drug Safety Testing Market Size and Forecast (2020-2031)

7 EUROPE

7.1 Europe Drug Safety Testing Consumption Value by Type (2020-2031)
7.2 Europe Drug Safety Testing Consumption Value by Application (2020-2031)
7.3 Europe Drug Safety Testing Market Size by Country
  7.3.1 Europe Drug Safety Testing Consumption Value by Country (2020-2031)
  7.3.2 Germany Drug Safety Testing Market Size and Forecast (2020-2031)
  7.3.3 France Drug Safety Testing Market Size and Forecast (2020-2031)
  7.3.4 United Kingdom Drug Safety Testing Market Size and Forecast (2020-2031)
  7.3.5 Russia Drug Safety Testing Market Size and Forecast (2020-2031)
  7.3.6 Italy Drug Safety Testing Market Size and Forecast (2020-2031)

8 ASIA-PACIFIC

8.1 Asia-Pacific Drug Safety Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Drug Safety Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Drug Safety Testing Market Size by Region
  8.3.1 Asia-Pacific Drug Safety Testing Consumption Value by Region (2020-2031)
  8.3.2 China Drug Safety Testing Market Size and Forecast (2020-2031)
  8.3.3 Japan Drug Safety Testing Market Size and Forecast (2020-2031)
  8.3.4 South Korea Drug Safety Testing Market Size and Forecast (2020-2031)
  8.3.5 India Drug Safety Testing Market Size and Forecast (2020-2031)
  8.3.6 Southeast Asia Drug Safety Testing Market Size and Forecast (2020-2031)
  8.3.7 Australia Drug Safety Testing Market Size and Forecast (2020-2031)

9 SOUTH AMERICA

9.1 South America Drug Safety Testing Consumption Value by Type (2020-2031)
9.2 South America Drug Safety Testing Consumption Value by Application (2020-2031)
9.3 South America Drug Safety Testing Market Size by Country
  9.3.1 South America Drug Safety Testing Consumption Value by Country (2020-2031)
  9.3.2 Brazil Drug Safety Testing Market Size and Forecast (2020-2031)
  9.3.3 Argentina Drug Safety Testing Market Size and Forecast (2020-2031)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Drug Safety Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Drug Safety Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Drug Safety Testing Market Size by Country
  10.3.1 Middle East & Africa Drug Safety Testing Consumption Value by Country (2020-2031)
  10.3.2 Turkey Drug Safety Testing Market Size and Forecast (2020-2031)
  10.3.3 Saudi Arabia Drug Safety Testing Market Size and Forecast (2020-2031)
  10.3.4 UAE Drug Safety Testing Market Size and Forecast (2020-2031)

11 MARKET DYNAMICS

11.1 Drug Safety Testing Market Drivers
11.2 Drug Safety Testing Market Restraints
11.3 Drug Safety Testing Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Drug Safety Testing Industry Chain
12.2 Drug Safety Testing Upstream Analysis
12.3 Drug Safety Testing Midstream Analysis
12.4 Drug Safety Testing Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


LIST OF TABLES

Table 1. Global Drug Safety Testing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Drug Safety Testing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Drug Safety Testing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Drug Safety Testing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. ArisGlobal LLC Company Information, Head Office, and Major Competitors
Table 6. ArisGlobal LLC Major Business
Table 7. ArisGlobal LLC Drug Safety Testing Product and Solutions
Table 8. ArisGlobal LLC Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. ArisGlobal LLC Recent Developments and Future Plans
Table 10. Eurofins Company Information, Head Office, and Major Competitors
Table 11. Eurofins Major Business
Table 12. Eurofins Drug Safety Testing Product and Solutions
Table 13. Eurofins Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Eurofins Recent Developments and Future Plans
Table 15. Clario Company Information, Head Office, and Major Competitors
Table 16. Clario Major Business
Table 17. Clario Drug Safety Testing Product and Solutions
Table 18. Clario Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Charles River Company Information, Head Office, and Major Competitors
Table 20. Charles River Major Business
Table 21. Charles River Drug Safety Testing Product and Solutions
Table 22. Charles River Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Charles River Recent Developments and Future Plans
Table 24. Pace Analytical Services Company Information, Head Office, and Major Competitors
Table 25. Pace Analytical Services Major Business
Table 26. Pace Analytical Services Drug Safety Testing Product and Solutions
Table 27. Pace Analytical Services Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Pace Analytical Services Recent Developments and Future Plans
Table 29. LabCorp Company Information, Head Office, and Major Competitors
Table 30. LabCorp Major Business
Table 31. LabCorp Drug Safety Testing Product and Solutions
Table 32. LabCorp Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LabCorp Recent Developments and Future Plans
Table 34. ICON plc. Company Information, Head Office, and Major Competitors
Table 35. ICON plc. Major Business
Table 36. ICON plc. Drug Safety Testing Product and Solutions
Table 37. ICON plc. Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. ICON plc. Recent Developments and Future Plans
Table 39. Boston Analytical Company Information, Head Office, and Major Competitors
Table 40. Boston Analytical Major Business
Table 41. Boston Analytical Drug Safety Testing Product and Solutions
Table 42. Boston Analytical Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Boston Analytical Recent Developments and Future Plans
Table 44. Catalent Company Information, Head Office, and Major Competitors
Table 45. Catalent Major Business
Table 46. Catalent Drug Safety Testing Product and Solutions
Table 47. Catalent Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Catalent Recent Developments and Future Plans
Table 49. Parexel International Corporation Company Information, Head Office, and Major Competitors
Table 50. Parexel International Corporation Major Business
Table 51. Parexel International Corporation Drug Safety Testing Product and Solutions
Table 52. Parexel International Corporation Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Parexel International Corporation Recent Developments and Future Plans
Table 54. Altasciences Company Information, Head Office, and Major Competitors
Table 55. Altasciences Major Business
Table 56. Altasciences Drug Safety Testing Product and Solutions
Table 57. Altasciences Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Altasciences Recent Developments and Future Plans
Table 59. Hangzhou Huante Biotechnology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 60. Hangzhou Huante Biotechnology Co., Ltd. Major Business
Table 61. Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product and Solutions
Table 62. Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Hangzhou Huante Biotechnology Co., Ltd. Recent Developments and Future Plans
Table 64. Boende Testing Company Information, Head Office, and Major Competitors
Table 65. Boende Testing Major Business
Table 66. Boende Testing Drug Safety Testing Product and Solutions
Table 67. Boende Testing Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Boende Testing Recent Developments and Future Plans
Table 69. Microspectroscopy Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 70. Microspectroscopy Technology Co., Ltd. Major Business
Table 71. Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product and Solutions
Table 72. Microspectroscopy Technology Co., Ltd. Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Microspectroscopy Technology Co., Ltd. Recent Developments and Future Plans
Table 74. Pharmaron Company Information, Head Office, and Major Competitors
Table 75. Pharmaron Major Business
Table 76. Pharmaron Drug Safety Testing Product and Solutions
Table 77. Pharmaron Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Pharmaron Recent Developments and Future Plans
Table 79. JOINN Company Information, Head Office, and Major Competitors
Table 80. JOINN Major Business
Table 81. JOINN Drug Safety Testing Product and Solutions
Table 82. JOINN Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. JOINN Recent Developments and Future Plans
Table 84. Shanghai InnoStar Bio-tech Co., Ltd Company Information, Head Office, and Major Competitors
Table 85. Shanghai InnoStar Bio-tech Co., Ltd Major Business
Table 86. Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product and Solutions
Table 87. Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Shanghai InnoStar Bio-tech Co., Ltd Recent Developments and Future Plans
Table 89. WESTCHINA-FRONTIE PHARMA TECH Company Information, Head Office, and Major Competitors
Table 90. WESTCHINA-FRONTIE PHARMA TECH Major Business
Table 91. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product and Solutions
Table 92. WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. WESTCHINA-FRONTIE PHARMA TECH Recent Developments and Future Plans
Table 94. Shanghai Medicilon Company Information, Head Office, and Major Competitors
Table 95. Shanghai Medicilon Major Business
Table 96. Shanghai Medicilon Drug Safety Testing Product and Solutions
Table 97. Shanghai Medicilon Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Shanghai Medicilon Recent Developments and Future Plans
Table 99. Hangzhou Rongchuang Biological Co., Ltd. Company Information, Head Office, and Major Competitors
Table 100. Hangzhou Rongchuang Biological Co., Ltd. Major Business
Table 101. Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product and Solutions
Table 102. Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Hangzhou Rongchuang Biological Co., Ltd. Recent Developments and Future Plans
Table 104. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 105. WuXi AppTec Major Business
Table 106. WuXi AppTec Drug Safety Testing Product and Solutions
Table 107. WuXi AppTec Drug Safety Testing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. WuXi AppTec Recent Developments and Future Plans
Table 109. Global Drug Safety Testing Revenue (USD Million) by Players (2020-2025)
Table 110. Global Drug Safety Testing Revenue Share by Players (2020-2025)
Table 111. Breakdown of Drug Safety Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 112. Market Position of Players in Drug Safety Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 113. Head Office of Key Drug Safety Testing Players
Table 114. Drug Safety Testing Market: Company Product Type Footprint
Table 115. Drug Safety Testing Market: Company Product Application Footprint
Table 116. Drug Safety Testing New Market Entrants and Barriers to Market Entry
Table 117. Drug Safety Testing Mergers, Acquisition, Agreements, and Collaborations
Table 118. Global Drug Safety Testing Consumption Value (USD Million) by Type (2020-2025)
Table 119. Global Drug Safety Testing Consumption Value Share by Type (2020-2025)
Table 120. Global Drug Safety Testing Consumption Value Forecast by Type (2026-2031)
Table 121. Global Drug Safety Testing Consumption Value by Application (2020-2025)
Table 122. Global Drug Safety Testing Consumption Value Forecast by Application (2026-2031)
Table 123. North America Drug Safety Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 124. North America Drug Safety Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 125. North America Drug Safety Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 126. North America Drug Safety Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 127. North America Drug Safety Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 128. North America Drug Safety Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 129. Europe Drug Safety Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 130. Europe Drug Safety Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 131. Europe Drug Safety Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 132. Europe Drug Safety Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 133. Europe Drug Safety Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 134. Europe Drug Safety Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 135. Asia-Pacific Drug Safety Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 136. Asia-Pacific Drug Safety Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 137. Asia-Pacific Drug Safety Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 138. Asia-Pacific Drug Safety Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 139. Asia-Pacific Drug Safety Testing Consumption Value by Region (2020-2025) & (USD Million)
Table 140. Asia-Pacific Drug Safety Testing Consumption Value by Region (2026-2031) & (USD Million)
Table 141. South America Drug Safety Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 142. South America Drug Safety Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 143. South America Drug Safety Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 144. South America Drug Safety Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 145. South America Drug Safety Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 146. South America Drug Safety Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 147. Middle East & Africa Drug Safety Testing Consumption Value by Type (2020-2025) & (USD Million)
Table 148. Middle East & Africa Drug Safety Testing Consumption Value by Type (2026-2031) & (USD Million)
Table 149. Middle East & Africa Drug Safety Testing Consumption Value by Application (2020-2025) & (USD Million)
Table 150. Middle East & Africa Drug Safety Testing Consumption Value by Application (2026-2031) & (USD Million)
Table 151. Middle East & Africa Drug Safety Testing Consumption Value by Country (2020-2025) & (USD Million)
Table 152. Middle East & Africa Drug Safety Testing Consumption Value by Country (2026-2031) & (USD Million)
Table 153. Global Key Players of Drug Safety Testing Upstream (Raw Materials)
Table 154. Global Drug Safety Testing Typical Customers

LIST OF FIGURES

Figure 1. Drug Safety Testing Picture
Figure 2. Global Drug Safety Testing Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Drug Safety Testing Consumption Value Market Share by Type in 2024
Figure 4. Drug Testing
Figure 5. Drug Analysis
Figure 6. Global Drug Safety Testing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Drug Safety Testing Consumption Value Market Share by Application in 2024
Figure 8. Pharmaceutical Company Picture
Figure 9. Biotechnology Company Picture
Figure 10. Medical Device Manufacturer Picture
Figure 11. Other Picture
Figure 12. Global Drug Safety Testing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Drug Safety Testing Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Drug Safety Testing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Drug Safety Testing Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Drug Safety Testing Consumption Value Market Share by Region in 2024
Figure 17. North America Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Drug Safety Testing Revenue Share by Players in 2024
Figure 24. Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Drug Safety Testing by Player Revenue in 2024
Figure 26. Top 3 Drug Safety Testing Players Market Share in 2024
Figure 27. Top 6 Drug Safety Testing Players Market Share in 2024
Figure 28. Global Drug Safety Testing Consumption Value Share by Type (2020-2025)
Figure 29. Global Drug Safety Testing Market Share Forecast by Type (2026-2031)
Figure 30. Global Drug Safety Testing Consumption Value Share by Application (2020-2025)
Figure 31. Global Drug Safety Testing Market Share Forecast by Application (2026-2031)
Figure 32. North America Drug Safety Testing Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Drug Safety Testing Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Drug Safety Testing Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Drug Safety Testing Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Drug Safety Testing Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Drug Safety Testing Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 42. France Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Drug Safety Testing Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Drug Safety Testing Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Drug Safety Testing Consumption Value Market Share by Region (2020-2031)
Figure 49. China Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 52. India Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Drug Safety Testing Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Drug Safety Testing Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Drug Safety Testing Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Drug Safety Testing Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Drug Safety Testing Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Drug Safety Testing Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Drug Safety Testing Consumption Value (2020-2031) & (USD Million)
Figure 66. Drug Safety Testing Market Drivers
Figure 67. Drug Safety Testing Market Restraints
Figure 68. Drug Safety Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Drug Safety Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source